sirolimus
AssetSmall moleculeAlso rapamycin, nab-Sirolimus, RAPAMUNE, Sirolimus (albumin - bound)
mTOR inhibitor delivered perivascularly via a collagen implant to improve arteriovenous fistula maturation.
- Stage
- Phase 3
- Modality
- Small molecule
- Target
- Autophagy
- Indications
- 51
- Trials
- 535
- Developers
- 14
Indications
51Aged
Phase 3COMPLETEDNCT00254709clinicaltrials.gov7 Oct 2026
Aging
Phase 3ACTIVE_NOT_RECRUITINGNCT07475546clinicaltrials.gov7 Oct 2026
Arteriovenous fistula
Phase 3COMPLETEDNCT05425056clinicaltrials.gov7 Oct 2026
48 more
- Targets and what it contains6
- Owner and partners14
- Trials535
- Evidence for its targets5
- Competitors12
- Aging relevance7
- Signals15
Every asset’s record: target, stage, trials and the evidence behind it.
See ProUpdated 7 Oct 2026 · 50 sources